baber/WOPTO huggingface dataset:
Patent NZ-535139-A (NZ)
Title: Hemiasterlin derivatives and uses thereof in the treatment of cancer
Inventor: KOWALCZYK JAMES J
IPC: A61K38/08
Filed: 2003-03-21
Abstract: Disclosed are Hemiasterlin analogs of general formula Ic with substituents as defined in the specification, methods for the synthesis and methods for the use thereof in the treatment of cancer. The disclosed compounds also find use in the prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting.
Patent NZ-542130-A (NZ)
Title: Teledioptic lens system and method for using the same
Inventor: PEYMAN GHOLAM
IPC: A61F2/16
Filed: 2004-02-25
Abstract: An intraocular lens system for implantation in the eye to modify the lens system of the eye comprising the cornea and the natural or existing artificial lens in the eye. The system comprises a lens having a high minus portion, adapted to be implanted in the eye to create a lens system that functions as a teledioptic lens system which, when used without an external lens, provides unmagnified and peripherally unrestricted vision and which, when used with an external lens, provides magnified and peripherally restricted vision to correct for macular degeneration. The lens can be attached to the iris, to a portion of the iris that was removed by iridectomy, or can be implanted in the cornea. The lens can also include a plus portion that is surrounded by the high minus portion. The high minus portion is preferably about one to about three millimeters in diameter, and can have an outer perimeter with no surrounding material or can be surrounded by a plus, minus or toric lens. Also disclosed is a method for using the intraocular lens system.
Patent NZ-543120-A (NZ)
Title: An aqueous, flowable concentrate composition of pendimethalin
Inventor: GOLDSMITH ANDREW
IPC: A01N33/18
Filed: 2004-04-13
Abstract: The present disclosure relates to a flowable, aqueous concentrate composition of pendimethalin with improved storage stability and not showing a slowed release rate of the active ingredient containing i) particles a) of microencapsulated pendimethalin, ii) particles b) of non-encapsulated pendimethalin and iii) at least one surface active substance.
Patent NZ-550661-A (NZ)
Title: A method or apparatus for determining performance data in a gaming system
Inventor: WRIGHT DEAN
IPC: A63F13/00
Filed: 2005-05-09
Abstract: A method and apparatus for determining performance data in a gaming system is provided. The method comprises the steps of recording the receipt of one or more gaming credits in a credit record, updating the record as the credit is used and/ or a prize is awarded and displaying data indicative of the value and credit remaining to a user. The method can be used to provide a credit meter on a game machine or network of machines.
Patent NZ-553117-A (NZ)
Title: c-9 t-11 conjugated linoleic acid-enriched milk fat and uses thereof
Inventor: KANWAR RUPINDER KAUR
Filed: 2004-05-11
Abstract: Disclosed is the use of milk fat enriched with c-9, t-l l conjugated linoleic acid (CLA) or a salt, ester or precursor thereof for treating or preventing a condition associated with one or more of leukocyte infiltration, eosinophilia, IgE secretion, airway remodelling, bronchoconstriction and mucus hypersecretion.
Patent NZ-556122-A (NZ)
Title: A food preparation mould
Inventor: HAMBLIN GEOFFREY RONALD
IPC: A21B3/13
Filed: 2005-12-23
Abstract: A mould 10 comprising a base 11, a collar 12 having a continuous wall 14 that upstands from the base 11 with a lower edge 16 of the collar abutting the base 11, tabs 25 extending from the lower edge 16 of the base 11, retaining means 18 in the base 11 which accept the tabs 25 and act to retain the lower edge 16 of the collar 12 in proximity with the base 11, and an insert 19 which is placed within the mould cavity 17.
Patent NZ-556699-A (NZ)
Title: Dairy product and process
Inventor: FLETCHER KATRINA
IPC: A23C9/142
Filed: 2004-10-12
Abstract: Disclosed is an infant formula comprising, beta-serum or low-lactose beta-serum. The formula may also comprise lactose, vegetable oils, skim milk powder and whey protein concentrate. Also disclosed is an infant formula comprising as an ingredient a fraction obtained from beta-serum enriched in polar lipids or depleted in neutral lipids or both.
Patent NZ-556737-A (NZ)
Title: New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
Inventor: VISCOMI GIUSEPPE CLAUDIO
IPC: C07D498/22
Filed: 2006-02-27
Abstract: Disclosed is a process for the production of rifaximin delta, wherein said process comprises reacting a molar equivalent of rifamycin O with an excess of 2-amino-4-methylpyridine in a solvent mixture made of water and ethyl alcohol in volumetric ratios between 1:1 and 2:1 for a period of time between 2 and 8 hours at a temperature between 40 degree C and 60 degree C, the reaction mass is treated at room temperature with a solution of ascorbic acid in a mixture of water, ethyl alcohol and concentrated aqueous hydrochloric acid, the reaction mass is brought to pH 2.0 by means of concentrated aqueous solution of hydrochloric acid, the suspension is filtered, the solid obtained is washed with the same water/ethyl alcohol solvent mixture used in the reaction to obtain a raw rifaximin; the raw rifaximin so obtained is purified by dissolving it in ethyl alcohol at a temperature between 45 degree C and 65 degree C, lowering the temperature of the suspension at values between 28 degree C and 32 degree C, the so obtained suspension is kept between 40 degree C and 50 degree C under stirring for a period of time between 6 and 24 hours, then it is cooled, in a period of time between 15 minutes and one hour, to 0 degree C before being filtered, the solid is washed with water and dried at a temperature between the room temperature and 105 degree C for a period of time between 2 and 72 hours, until Rifaximin delta is formed.
Patent NZ-560414-A (NZ)
Title: Monoclonal antibodies against prostate specific membrane antigen (PSMA) lacking in fucosyl residues
Inventor: CARDARELLI JOSEPHINE M
IPC: A61P35/00
Filed: 2006-02-17
Abstract: Provided is isolated anti-prostate specific membrane antigen (PSMA) antibody, which comprises specified CDR1, CDR2 and CDR3 in heavy and light chains. Further provided are non-human host cells comprising the antibody and uses of the antibody in the manufacture of medicaments to treat tumors.
Patent NZ-562952-A (NZ)
Title: Configuring security systems by receiving device programming files
Inventor: HAMMADOU TARIK
IPC: G06F9/44
Filed: 2006-04-12
Abstract: Disclosed is a method for configuring installed security systems. The method includes a configurable device operable to capture video information and perform a plurality of security functions in an installed security system receiving at least one device programming file from a remote server via a network. The device is programmed to add a new security function associated with a new video analytic application to the device, the programming based on the received programming file. The security functions are associated with a plurality of video analytic and/or video processing applications.
Patent NZ-564592-A (NZ)
Title: Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
Inventor: KORMAN ALAN J
IPC: A61P35/00
Filed: 2006-06-30
Abstract: Disclosed is a human monoclonal antibody or antigen-binding portion thereof which specifically binds to PD-L1, wherein the antibody or antigen-binding portion thereof crosscompetes for binding to PD-L1 with a reference antibody or reference antigen-binding portion thereof comprising: a heavy chain variable region that comprises amino acids having the sequence set forth in SEQ ID NO: 2; and a light chain variable region that comprises amino acids having the sequence set forth in SEQ NO: 12. Also a human monoclonal antibody or antigen-binding portion thereof which specifically binds to PD-L1, wherein the antibody or antigen-binding portion thereof crosscompetes for binding to PD-Li with a reference antibody or reference antigen-binding portion thereof comprising a heavy chain variable region that comprises CDR1, CDR2, and CDR3 domains; and a light chain variable region that comprises CDR1, CDR2, and CDR3 domains, wherein: (a) the heavy chain variable region CDR3 comprises amino acids having the sequence set forth in SEQ ID NO: 42; (b) the light chain variable region CDR3 comprises amino acids having the sequence set forth in SEQ ID NO: 72, and conservative modifications thereof. Further disclosed is the use of the said antibodies for the preparation of a medicament for modulating an immune response in a subject.
Patent NZ-573172-A (NZ)
Title: Injection device that receives a syringe, extends it, discharges, and retracts automatically
Inventor: BARROW-WILLIAMS TIMOTHY DONALD
IPC: A61M5/20
Filed: 2007-05-30
Abstract: Disclosed is an injection device with automatic retraction. The device includes a damping element (125) which acts between a syringe carrier (122) and a restraining component (119) to restrain the advancement and cushion the impact as they come into contact, thereby reducing the transmission of energy from the impact to the components of a drive (130, 131, 134) and preventing their fracture. The drive which acts upon the syringe to advance it from its retracted position to its extended position and discharge its contents through a discharge nozzle.
Patent NZ-575476-A (NZ)
Title: Alphavirus replicon particles encoding il- 12 as immunological adjuvants
Inventor: SMITH JONATHAN F
IPC: A61K35/76
Filed: 2007-09-12
Abstract: The use of an antigen and alphavirus replicon particles expressing IL-12 in the manufacture of at least one medicament formulated for administration to a subject to enhance an immune response to the antigen, wherein the alphavirus replicon particles are derived from Venezuelan Equine Encephalitis (VEE) virus.
Patent NZ-578826-A (NZ)
Title: New process for obtaining the crystalline form V of agomelatine
Inventor: MARTINS DAMIEN
IPC: C07C233/17
Filed: 2009-08-03
Abstract: Disclosed is the process for obtaining the crystalline form V of agomelatine of formula (I) characterised in that a solution of agomelatine that has been dissolved in one or two solvents which are miscible in any proportion and whose boiling point is less than 120 degrees Celsius is atomised in a spray dryer.
Patent NZ-580289-A (NZ)
Title: Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
Inventor: HARATS DROR
IPC: C07H21/04
Filed: 2005-11-14
Abstract: Provided is a nucleic acid construct comprising an isolated polynucleotide which comprises a conditionally replicating adenovirus transcriptionally linked to a pre-proendothelin-1 promoter, wherein said promoter selectively directs transcription of said adenovirus in angiogenic endothelial cells, and wherein said nucleic acid construct is devoid of non-viral heterologous sequences encoding pro- or anti-angiogenic agents. The promoter can be PPE-1-3X promoter.
Patent NZ-584321-A (NZ)
Title: Flight selection method
Inventor: MOORHEAD SCOTT
IPC: G06F3/0482
Filed: 2010-01-19
Abstract: A web-server is programmed to process flight data relating to flights to produce display data. The display data is for displaying by a remote computer in accordance with a flight search query. The display data includes flight representations displayed relative to a timeline, at least one flight representation being associated with more than one fare indicator. A flight selection method including the step of processing flight data relating to flights to produce display data using a computerised device is also disclosed.
Patent NZ-590324-A (NZ)
Title: Vaccine against amyloid folding intermediate
Inventor: HOOGERHOUT PETER
IPC: G01N33/68
Filed: 2009-07-01
Abstract: Disclosed is a vaccine to prevent Alzheimers disease via an amyloid cleaving analogue.
Patent NZ-590555-A (NZ)
Title: Method for characterizing, in particular for quantifying, molecular markers that are intracellularly absorbed from tissues by blood macrophages that are recirculated from the tissues into the circulatory system
Inventor: BROZEK WOLFANG
IPC: G01N33/50
Filed: 2009-08-04
Abstract: Disclosed is an ex vivo method for characterizing molecular marker(s) that are intracellularly absorbed from tissue by blood macrophages that are recirculated from the tissue into the circulatory system, comprising the following steps: - applying an agent to whole blood, which inhibits coagulation and/or agglomeration of whole blood; - performing a selection of blood macrophages or leukocyte populations containing blood macrophages from the whole blood, wherein - the selection is performed by means of a positive selection using antibodies directed against the surface marker CD16; a positive selection using antibodies directed against the surface marker CD14 is performed; and a negative selection for excluding cells with the surface markers CD56 and/or CD57 and/or CD161 is performed using antibodies directed against the surface markers CD56 and/or CD57 and/or CD161; - performing a perforation and/or lysis of the selected blood macrophages or leukocyte populations containing blood macrophages; - performing a qualitative and quantitative determination of phagocytosed, non blood macrophage markers, namely from molecular markers arising from tissue, in an Elisa plate.
Patent NZ-592923-A (NZ)
Title: Trace elements
Inventor: SMITH WILLIAM ALFRED
IPC: A61K33/24
Filed: 2009-11-30
Abstract: Disclosed is a trace element solution, which comprises at least the following metals: (a) zinc in a concentration of at least 60 mg/ml; (b) manganese in a concentration of at least 10 mg/ml; (c) selenium in a concentration of at least 5 mg/ml; and (d) copper in a concentration of at least 15 mg/ml; and which comprises a concentration of the metals of at least 90 mg/ml and in which the ratio of zinc to manganese is at least 2: 1, the ratio of zinc to copper is at least 2: 1, and the ratio of zinc to selenium is at least 4:1.
Patent NZ-592939-A (NZ)
Title: Compression garment with seam corresponding to muscle ridge
Inventor: DUFFY BRADLEY THOMAS
IPC: A41D1/08
Filed: 2005-09-23
Abstract: 592939 A compression garment for clothing a body part which includes a muscle ridge, the garment having a first panel of stretchable material joined to a second panel of stretchable material by a seam, wherein in use at least part of the seam corresponds to at least part of the muscle ridge, and wherein the muscle ridge is chosen from the following: a) a lateral edge of the gluteus maximus near the sacrum and a lateral edge of the hamstring tendon; and one of: b) a ridge between the long head of the rectus femoris and the semitendinosus muscle group; c) an area over the popliteal fossa between the heads of the medial and lateral gastrocnemius; or one of: d) a ridge of the vastus lateralis and a ridge of the vastus medialis; e) a lateral edge of the serratus anterior muscle group; f) a lateral edge of the serratus anterior and external deltoid muscle group; g) a lateral edge of the latisimis dorsi muscle group; and h) a ridge in the biceps brachii.
Patent NZ-593950-A (NZ)
Title: Implantable devices for treating hiv
Inventor: SCHACHTER DEBORAH M
IPC: A61K9/00
Filed: 2009-12-24
Abstract: Abstract 593950 The present disclosure relates to an implantable device for treating HIV infection. Disclosed is an implantable device comprising a biocompatible, biodegradable polymer mixed with TMC278 and with one or more release-enhancing agents selected from the group consisting of poloxamers, polysorbates, and a combination of dimethyl sulfoxide (DMSO) and poly( vinyl pyrrolidone)(PVP).
Patent NZ-597480-A (NZ)
Title: Load balancing system with a plurality of meters receiving instructions for phase selection
Inventor: PAMULAPARTHY BALA KRISHNA
IPC: G01R29/16
Filed: 2012-01-06
Abstract: Disclosed is a load balancing system (10) for a power distribution system, comprising an obtainer (40), a determinator (50) and a transmitter (60). The obtainer (40) obtains load data from a plurality of meters (110A-110N), wherein each meter (110A-110N) is connected to one of a first, second or third phase of the power distribution system. The obtainer (40) includes an automatic meter reading device. The determinator (50) determines a balanced load distribution for the first, second and third phases of the power distribution system based on the obtained load data. The balanced load distribution indicates one of the first, second and third phases for each meter (110A-110N) to switch connection to. The transmitter (60) transmits balanced load distribution commands including the balanced load distribution to each of the meters (110A-110N). Each meter (110A-110N) then switches a phase connection to the distribution power supply system according to the balanced load distribution commands.
Patent NZ-600329-A (NZ)
Title: Cooking utensil
Inventor: SOLARI CLIVE
IPC: A47J43/28
Filed: 2010-12-24
Abstract: 600329 A multifunctional barbeque cooking spatula (10) is disclosed. The spatula includes a functional member (20) configured to engage a food item and a handle member (40) for gripping the utensil (10) and for moving the functional member (20). The functional member (20) includes a blade (25) having a pair of opposite surfaces (26, 27) meeting at a pair of opposite lateral edges (28, 29). One of the lateral edges (29) is sharpened to form a cutting knife edge and the other one of the lateral edges (28) includes prongs (31) and a curved cutting edge (32). At least one of the planar surfaces has one or more recesses (34) that do not pass entirely through the blade in order to reduce friction between the blade and a food item. In another embodiment the spatula has an extendable handle (40).
Patent NZ-600944-A (NZ)
Title: Method and facility for drying pasty materials, in particular sludge from wastewater treatment plants and generation of thermal energy
Inventor: STANLEY BRUCE
IPC: C02F11/13
Filed: 2010-12-27
Abstract: A method for drying pasty materials, in particular sludge from wastewater treatment plants, including a first indirect drying stage (1) supplied with a heat-transfer fluid, which outputs (1a, 1b) pre-dried sludge and water vapour; a step (6) of forming sludge at the outlet of the first stage, and a second stage of drying (7) pre-dried sludge that is heated by means of a heating gas, in particular air, the second stage producing (7b) dried sludge. At least one portion of the dried sludge produced by the second stage is incinerated (23) to produce thermal energy, and at least one portion of said thermal energy is used to heat the heat-transfer fluid of the first drying stage.
Patent NZ-601444-A (NZ)
Title: Mechanical treatment of processed biomass
Inventor: MEDOFF MARSHALL
IPC: B02C19/00
Filed: 2011-02-11
Abstract: A method of mechanically treating a structurally modified cellulosic or lignocellulosic biomass feedstock material is disclosed, wherein the a molecular structure of the structurally modified cellulosic or lignocellulosic biomass has been modified or changed by subjecting it to a treatment selected from the group consisting of radiation (such as irradiating with electron beam radiation, wherein irradiating with radiation comprises delivering a dose of from greater than 10 Mrad to about 500 Mrad), sonication, pyrolysis, oxidation, steam explosion, chemical treatment, or combinations thereof, and then mechanically treating the structurally modified feedstock, wherein the mechanical treatment comprises a process selected from the group consisting of cutting, milling, grinding, pressing, shearing and chopping. The method further comprises saccharifying and fermenting the structurally modified, mechanically treated feedstock or combining said feedstock with a microorganism comprising a bacterium and/or enzyme, wherein the microorganism utilises the feedstock to produce hydrogen, an alcohol, an organic acid, a hydrocarbon and/or biodiesel.
Patent NZ-604662-A (NZ)
Title: Pharmaceutical dosage form comprising 6’-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4’,9’-dihydro-3’h-spiro[cyclohexane-1,1’-pyrano[3,4,b]indol]-4-amine
Inventor: GRÜNING NADJA
IPC: A61K9/107
Filed: 2011-08-04
Abstract: Disclosed is the use of a pharmaceutical dosage form in the manufacture of a medicament for the treatment of pain, wherein the dosage form contains 6’-fluoro-(N-methyl- or N,N-dimethyl)-4-phenyl-4’,9’-dihydro-3’H-spiro[cyclohexane-1,1’-pyrano[3,4,b]indol]-4-amine represented by formula (I) or a physiologically acceptable salt thereof, and a self-emulsifying formulation; wherein the pharmaceutical dosage form is administered twice daily, once daily or less frequently. The pharmaceutical dosage form is suitable for treating pain selected from acute, visceral, neuropathic or chronic pain.
Patent NZ-607711-A (NZ)
Title: Antibodies directed to her-3 and uses thereof
Inventor: TREDER MARTIN
IPC: A61K39/395
Filed: 2006-12-29
Abstract: Patent No. 607711 Disclosed is an isolated antibody that binds to HER-3, characterized in that the CDR1 of the heavy chain consists of a sequence represented by GYTFTGYYMH, the CDR2 of the heavy chain consists of a sequence represented by WINPNIGGTNCAQKFQG, the CDR3 of the heavy chain consists of a sequence represented by GGRYSSSWSYYYYGMDV, the CDR1 of the light chain consists of a sequence represented by KSSQSLLLSDGGTYLY, the CDR2 of the light chain consists of a sequence represented by EVSNRFS and the CDR3 of the light chain consists of a sequence represented by MQSMQLPIT.
Patent NZ-611733-A (NZ)
Title: A device for detecting moving containers
Inventor: BELLINI MARCO
IPC: B65C9/06
Filed: 2011-11-30
Abstract: Disclosed is a device (1) for detecting containers moving along a conveyor and a conveyor for containers. The disclosure notes that existing devices for detecting containers comprise a plurality of sensors mounted on a plate of a carousel. The increased number of sensors increases the overall dimensions of the carousel. Furthermore, sensors are connected to the carousel using brackets which make it difficult to access the internal components of the carousel for maintenance. The device (1) for detecting containers comprises a support structure; at least one detection sensor (15); synchronising means and motor-driven means (40). The at least one detection sensor (15) is connected to the support structure and is operatively associated with a container moving along the conveyor so as to detect a characteristic of the container. The synchronising means synchronises the sensor (15) with the container. The synchronising means are active on the sensor (15) to move it so that the sensor (15) follows the container along at least one part of a feed path from an initial position to a final position. The synchronising means comprise a guide fixed to the support structure and a mobile structure (18) slidably mounted on the guide. The sensor (15) is fixed to the mobile structure (18) for moving at least from the initial position to the final position. The mobile structure (18) comprises a closed-loop transmission unit to which at least one sensor (15) is connected. The motor-driven means (40) moves the mobile structure (18) with respect to the support structure.
Patent NZ-618256-A (NZ)
Title: Navigation user interface in support of page-focused, touch- or gesture-based browsing experience
Inventor: MANDIC MIRKO
IPC: G06F3/048
Filed: 2011-10-09
Abstract: Disclosed is a method for displaying a user interface of a browser. The method comprises displaying a webpage using a web browser on a computing device (502) having a display device (507), and maintaining at least navigation instrumentalities (508, 510), including an address bar (506), in a dismissed state in which the instrumentalities (508, 510) are not viewable. The method further comprises monitoring user interaction (506a) with the webpage; and responsive to ascertaining that a user interaction (506a) is associated with a navigation related activity, invoking and visually presenting the navigation instrumentalities (508, 510), including the address bar (506), at the bottom (504) of the display device (507).